Achmea Investment Management B.V. Purchases 1,418 Shares of CME Group Inc. (NASDAQ:CME)

Achmea Investment Management B.V. grew its position in shares of CME Group Inc. (NASDAQ:CME) by 1.0% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 137,125 shares of the financial services provider’s stock after acquiring an additional 1,418 shares during the quarter. Achmea Investment Management B.V.’s holdings in CME Group were worth $26,959,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also recently modified their holdings of CME. Vanguard Group Inc. grew its holdings in CME Group by 0.6% during the fourth quarter. Vanguard Group Inc. now owns 33,451,194 shares of the financial services provider’s stock worth $7,044,821,000 after buying an additional 215,044 shares in the last quarter. Capital International Investors grew its holdings in CME Group by 24.1% during the first quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock worth $3,403,557,000 after buying an additional 3,069,806 shares in the last quarter. Capital World Investors grew its holdings in CME Group by 8.7% during the fourth quarter. Capital World Investors now owns 14,589,867 shares of the financial services provider’s stock worth $3,072,654,000 after buying an additional 1,172,575 shares in the last quarter. Bank of New York Mellon Corp grew its holdings in CME Group by 2.9% during the first quarter. Bank of New York Mellon Corp now owns 6,793,988 shares of the financial services provider’s stock worth $1,462,678,000 after buying an additional 189,842 shares in the last quarter. Finally, Parnassus Investments LLC grew its holdings in CME Group by 0.4% during the fourth quarter. Parnassus Investments LLC now owns 5,667,384 shares of the financial services provider’s stock worth $1,193,551,000 after buying an additional 23,583 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.

Insider Buying and Selling

In related news, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the sale, the director now owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.30% of the stock is currently owned by insiders.

Analyst Ratings Changes

CME has been the subject of several recent research reports. Barclays upped their price target on CME Group from $208.00 to $209.00 and gave the stock an “equal weight” rating in a report on Thursday, July 25th. JPMorgan Chase & Co. upped their price objective on CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a research note on Thursday, July 25th. Bank of America downgraded CME Group from a “neutral” rating to an “underperform” rating and reduced their price objective for the company from $212.00 to $177.00 in a research note on Tuesday, September 3rd. Keefe, Bruyette & Woods upped their price objective on CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a research note on Thursday, July 25th. Finally, Deutsche Bank Aktiengesellschaft upped their price objective on CME Group from $193.00 to $200.00 and gave the company a “hold” rating in a research note on Thursday, August 15th. Four analysts have rated the stock with a sell rating, five have given a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $209.73.

CME Group Stock Up 0.1 %

Shares of NASDAQ CME opened at $218.59 on Thursday. CME Group Inc. has a one year low of $190.70 and a one year high of $223.80. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.02 and a quick ratio of 1.02. The business’s fifty day moving average price is $204.85 and its 200-day moving average price is $207.62. The stock has a market capitalization of $78.71 billion, a PE ratio of 24.87, a P/E/G ratio of 8.92 and a beta of 0.55.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.53 by $0.03. The business had revenue of $1.53 billion for the quarter, compared to analysts’ expectations of $1.53 billion. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The firm’s quarterly revenue was up 12.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.30 EPS. On average, equities research analysts anticipate that CME Group Inc. will post 9.94 EPS for the current year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Monday, September 9th will be issued a dividend of $1.15 per share. The ex-dividend date of this dividend is Monday, September 9th. This represents a $4.60 dividend on an annualized basis and a yield of 2.10%. CME Group’s dividend payout ratio (DPR) is 52.33%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.